Skip to main content
SpringerLink
Log in

Epidemiology of the Metabolic Syndrome

  • Chapter
  • First Online:
The Metabolic Syndrome

Abstract

Insulin resistance—an essential component of the metabolic syndrome—has been known for nearly 70 years. During the last 25 years numerous studies have shown that insulin resistance tend to occur concomitantly with a cluster of cardiovascular risk factors including increased blood pressure, lipid levels, obesity and a wide range of other factors associated with increased risk of developing CVD. This clustering of risk factors have been given many names, but during the last 10–15 years the label “Metabolic Syndrome” has been used as the common name for the condition. The definition has changed over time, and consequently it is difficult to compare epidemiological studies over time or between regions, as they have often used different definitions.

Independent of ethnicity, the prevalence of the metabolic syndrome increases by age. There are distinct effects of ethnicity, where the age-adjusted prevalence of the metabolic syndrome is highest in East-Asia and in the Middle East region. Within countries there are also marked differences with higher prevalence in Afro-American and Mexican-Hispanic groups than in white Caucasian groups in USA.

Based on a number of epidemiological studies, the clinical value of the “Metabolic Syndrome” has been questioned. The clinical relevance here refers to the issue—whether the presence of the metabolic syndrome predicts adverse outcome like diabetes and CVD, and whether it does so over and above the effect of the individual risk factors. Most studies indicate that it is the presence of the individual risk factors, not the syndrome that carries the clinically relevant information. Consequently, the syndrome may be a convenient term for a clustering of risk factors, but it seems to have limited clinical impact as an entity in itself.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Himsworth H (1936) Diabetes mellitus: a differentiation into insulin-sensitive and insulin-insensitive types. Lancet 1:127–130

    Article  Google Scholar 

  2. Yalow RS, Berson SA (1960) Plasma insulin concentrations in nondiabetic and early diabetic subjects: determinations by a new sensitive immunoassay technique. Diabetes 9:254–260

    PubMed  CAS  Google Scholar 

  3. Avogaro P, Crepaldi G, Enzi G, Tiengo A (1967) Associazione di iperlidemia, diabete mellito e obesita di medio grado. Acto Diabetol Lat 4:36–41

    Article  Google Scholar 

  4. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL (1983) Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 188:326–337

    Google Scholar 

  5. Stern MP, Haffner SM (1986) Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Atherosclerosis 6:123–130

    CAS  Google Scholar 

  6. Ferrannini E, Buzzigoli G, Bonadornna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N Engl J Med 317:350–357

    Article  PubMed  CAS  Google Scholar 

  7. Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607

    Article  PubMed  CAS  Google Scholar 

  8. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. WHO, Geneva

    Google Scholar 

  9. Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal. Diabetologia 48:1684–1699

    Article  PubMed  CAS  Google Scholar 

  10. Nakagami T, Qiao Q, Carstensen B, Nøhr-Hansen C, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K (2003) The DECODE-DECODA Study Group. Age, body mass index and Type 2 diabetes—associations modified by ethnicity. Diabetologia 46:1063–1070

    Article  PubMed  CAS  Google Scholar 

  11. Saad MF, Lilloja S, Nyomba BL et al (1991) Racial differences in the relation between blood pressure and insulin resistance. N Eng J Med 324:733–739

    Article  CAS  Google Scholar 

  12. Lee CM, Huxley RR, Woodward M et al (2008) The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region. Diabetes Res Clin Pract 8:377–380

    Article  Google Scholar 

  13. NCEP (2001) Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497

    Google Scholar 

  14. Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:442–443

    Article  PubMed  CAS  Google Scholar 

  15. Al-Daghri NM (2010) Extremely high prevalence of metabolic syndrome manifestations among Arab youth: a call for early intervention. Eur J Clin Invest 40:1063–1066

    Article  PubMed  Google Scholar 

  16. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P (2003) Prevalence of the metabolic syndrome among Omani adults. Diabetes Care 26:1781–1785

    Article  PubMed  Google Scholar 

  17. Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V (2002) Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross sectional evaluation. Atherosclerosis 165:285–292

    Article  PubMed  CAS  Google Scholar 

  18. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716

    Article  PubMed  Google Scholar 

  19. Gupta A, Gupta R, Sarna M, Rastogi S, Gupta VP, Kothari K (2003) Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract 61:69–76

    Article  PubMed  Google Scholar 

  20. Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH (2008) Prevalence of the metabolic syndrome among US adolescents using the definition from the international diabetes federation. Diabetes Care 31:587–589

    Article  PubMed  Google Scholar 

  21. Meigs JB, Wilson PWF, Nathan DM, D’Agostino RB, Williams K, Haffner SM (2003) Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 52:2160–2167

    Article  PubMed  CAS  Google Scholar 

  22. Li JB, Wang X, Zhang JX, Gu P, Zhang X, Chen CX, Guo R, Wu M (2010) Metabolic syndrome: prevalence and risk factors in southern China. J Int Med Res 38:1142–1148

    PubMed  Google Scholar 

  23. Cai H, Huang J, Xu G, Yang Z, Liu M, Mi Y, Liu W, Wang H, Qian D (2012) Prevalence and determinants of metabolic syndrome among women in Chinese rural areas. PLoS One 7(5):e36936

    Article  PubMed  CAS  Google Scholar 

  24. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359

    Article  PubMed  Google Scholar 

  25. Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Heine R, Wareham NJ, DECODE Study Group (2005) Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age? Diabet Med 22:1476–1481

    Article  PubMed  Google Scholar 

  26. Hu G, Qiao Q, Tuomilehto J et al (2004) Prevalence of the metabolic syndrome and its relation to all-cause mortality in non-diabetic European men and women. Arch Intern Med 164:1066–1076

    Article  PubMed  Google Scholar 

  27. Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens EJ, Pyörälä K, DECODE Insulin Study Group (2004) Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 47:1245–1256

    PubMed  CAS  Google Scholar 

  28. Gu D, Reynolds K, Wu X et al (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365:1398–1405

    Article  PubMed  Google Scholar 

  29. Ford ES, Giles WH, Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 27:2444–2449

    Article  PubMed  Google Scholar 

  30. Wasir JS, Misra A, Vikram NK, Pandey RM, Gupta R (2008) Comparison of definitions of the metabolic syndrome in adult Asian Indians. J Assoc Physicians India 56:158–164

    PubMed  CAS  Google Scholar 

  31. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman DJ, Jukema JW, Lennon L, Macfarlane PW, Murphy MB, Packard CJ, Stott DJ, Westendorp RG, Whincup PH, Shepherd J, Wannamethee SG (2008) Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 371:1927–1935

    Article  PubMed  Google Scholar 

  32. Lindström J, Tuomilehto J (2003) The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731

    Article  PubMed  Google Scholar 

  33. Glümer C, Carstensen B, Sandbæk A, Lauritzen T, Jørgensen T, Borch-Johnsen K (2004) A Danish diabetes risk score for targeted screening. Diabetes Care 27:727–733

    Article  PubMed  Google Scholar 

  34. Stern MP et al (2004) Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease. Diabetes Care 27:2676–2681

    Article  PubMed  Google Scholar 

  35. Stern MP, Williams K, Haffner SM (2002) Identification of individuals at high risk of type 2 diabetes: do we need the oral glucose tolerance test? Ann Intern Med 136:575–581

    PubMed  Google Scholar 

  36. Haffner SM, Miettenen H, Gaskill SP, Stern MP (1990) Metabolic predictors of hypertension: the San Antonio Heart Study. Arch Intern Med 156:1994–2000

    Article  Google Scholar 

  37. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847

    Article  PubMed  CAS  Google Scholar 

  38. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med 344:1343–1350

    Article  CAS  Google Scholar 

  39. Pan X, Li G, Hu Y et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and diabetes study. Diabetes Care 20:537–44

    Article  PubMed  CAS  Google Scholar 

  40. The Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with life style intervention or metformin. N Engl J Med 346:393–403

    Article  Google Scholar 

  41. Pyörälä M, Miettinen H, Halonen P, Laakso M, Pyörälä K (2000) Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 20:538–544

    Article  PubMed  Google Scholar 

  42. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–689

    Article  PubMed  CAS  Google Scholar 

  43. Girman CJ, Rhodes T, Mercuri M, Pyörälä K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M, S Group and the AFCAPS/TexCAPS Research Group (2004) The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93:136–141

    Article  PubMed  CAS  Google Scholar 

  44. Eddy DM, Schlessinger L, Heikes K (2008) The metabolic syndrome and cardiovascular risk: implications for clinical practice. Int J Obes 32(Suppl 2):S5–S10

    Article  CAS  Google Scholar 

  45. Herman WH, Smith PJ, Thomson TJ, Engelgau MM, Aubert RE (1995) A new and simple questionnaire to identify people at increased risk of undiagnosed diabetes. Diabetes Care 18:382–387

    Article  PubMed  CAS  Google Scholar 

  46. Ruige JB, Neeling JND, Kostence PJ, Bouter LM, Heine RJ (1997) Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 20:491–496

    Article  PubMed  CAS  Google Scholar 

  47. Baan CA, Ruige JB, Stolk RP, Witteman JC, Dekker JM, Heine RJ, Feskens EJ (1999) Performance of a predictive model to indentify undiagnosed diabetes in a health care setting. Diabetes Care 22:213–219

    Article  PubMed  CAS  Google Scholar 

  48. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ (2000) Diabetes risk score: towards earlier detection of Type 2 diabetes in general practice. Diabetes Metab Res Rev 16:164–171

    Article  PubMed  CAS  Google Scholar 

  49. Christensen JO, Sandbaek A, Laurtizen T, Borch-Johnsen K (2004) Population-based stepwise screening for unrecognised type 2 diabetes ineffective in general practice despite reliable algorithms. Diabetologia 47:1566–1573

    Article  PubMed  CAS  Google Scholar 

  50. Conroy RM, Pyörälä K, Fitzgerald AP et al (2003) Estimation of 10-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003

    Article  PubMed  CAS  Google Scholar 

  51. Hanson RL, Imperatore G, Bennett PH, Knowler WC (2002) Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 51:3120–3127

    Article  PubMed  CAS  Google Scholar 

  52. Ford ES (2005) Risk for all-cause mortality, cardiovascular disease and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28:1769–1778

    Article  PubMed  Google Scholar 

  53. Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB (2005) Metabolic Syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112:3066–3072

    Article  PubMed  CAS  Google Scholar 

  54. Meigs JB (2006) Metabolic Syndrome and risk for type 2 diabetes. Expert Rev Endocrinol Metab 1:57–66

    Article  CAS  Google Scholar 

  55. Burke JP, Williams K, Haffner SM, Villalpando CG, Stern MP (2001) Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care 24:1573–1578

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Holbæk Hospital, Smedelundsgade 60, 4300, Holbaek, Denmark

    Knut Borch-Johnsen

Authors
  1. Knut Borch-Johnsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Knut Borch-Johnsen .

Editor information

Editors and Affiliations

  1. Dept. Endocrinology, Odense University Hospital, Kloevervaenget 6 4, Odense C, 5000, Denmark

    Henning Beck-Nielsen

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Wien

About this chapter

Cite this chapter

Borch-Johnsen, K. (2013). Epidemiology of the Metabolic Syndrome. In: Beck-Nielsen, H. (eds) The Metabolic Syndrome. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1331-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1331-8_2

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1330-1

  • Online ISBN: 978-3-7091-1331-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation